PR Newswire
LAS VEGAS, March 17, 2026
The diabetes care devices market is largely propelled by the increasing global incidence of diabetes, which is influenced by higher obesity rates, sedentary habits, and an aging population. Heightened awareness of the benefits of early diagnosis and continuous glucose monitoring is driving the adoption of advanced solutions such as continuous glucose monitors (CGMs), insulin pumps, and smart insulin pens. Additionally, technological innovations, such as digital connectivity, AI integration, and wearable devices, are enhancing patient convenience and the precision of diabetes management.
LAS VEGAS, March 17, 2026 /PRNewswire/ — DelveInsight’s Diabetes Care Devices Market Insights report provides the current and forecast market analysis, individual leading diabetes care devices companies’ market shares, challenges, diabetes care devices market drivers, barriers, trends, and key diabetes care devices companies in the market.
https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg
Diabetes Care Devices Market Summary
- 2025 Diabetes Care Devices Market Size: ~USD 41 Billion
- 2034 Projected Diabetes Care Devices Market Size: ~USD 76 Billion
- Diabetes Care Devices Market Growth Rate (2026-2034): ~7%
- Largest Diabetes Care Devices Market: North America
- Largest Product Type Segment: Blood Glucose Monitoring Devices Category
- Key Companies in the Diabetes Care Devices Market: Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd., Eli Lilly and Company, Insulet Corporation, Abbott, Terumo Corporation, CeQur, EOFLOW CO., LTD, Sanofi, Medtronic, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, and others
To read more about the latest highlights related to the diabetes care devices market, get a snapshot of the key highlights @ https://www.delveinsight.com/sample-request/diabetes-care-devices-market
Key Factors Contributing to the Rise in Growth of the Diabetes Care Devices Market
- Increasing Prevalence of Diabetes: The global incidence of diabetes, especially type 2 diabetes, is rising due to sedentary lifestyles, obesity, aging populations, and unhealthy diets.
- Growing Awareness and Early Diagnosis: Greater health awareness and screening programs have led to earlier detection of diabetes. As a result, more patients are using diagnostic and monitoring devices such as glucose meters and continuous glucose monitoring (CGM) systems.
- Technological Advancements: Innovations in digital and connected health technologies have significantly improved the usability and accuracy of diabetes care products.
-
Rising Adoption of Self
‑
Monitoring Devices: Self-monitoring of blood glucose (SMBG) has increased as patients seek better control over their condition. Portable and user‑friendly devices support self‑management, reducing dependency on clinical visits. - Increasing Healthcare Expenditure and Insurance Coverage: Growth in healthcare spending, better insurance coverage, and reimbursement policies for diabetes devices have made these technologies more accessible and affordable, especially in developed economies.
- Focus on Personalized and Remote Care: The trend toward personalized medicine and telehealth solutions, accelerated by the COVID‑19 pandemic, boosts demand for remote glucose monitoring and insulin delivery systems.
- Supportive Government Initiatives: Public health programs and policies aimed at diabetes prevention and management, such as subsidized devices, awareness campaigns, and screening drives, facilitate market growth, particularly in emerging economies.
- Rising Geriatric Population: Population aging correlates strongly with higher diabetes prevalence. Older adults often require continuous management devices, further expanding market demand.
- Increased Investment & Strategic Partnerships: The market has seen significant investments, collaborations, and partnerships among device manufacturers, biotech firms, and software developers, driving innovation, product launches, and global distribution.
-
Demand for Minimally Invasive and Pain
‑
Free Solutions: Patients prefer pain‑free or minimally invasive glucose monitoring (e.g., CGM, flash glucose monitoring), fueling adoption over traditional finger‑stick devices.
Regional Diabetes Care Devices Market Insights
North America
- In 2025, North America accounted for the largest share, 41%, of the global diabetes care devices market.
- This growth is driven by the region’s high prevalence of diabetes, robust healthcare infrastructure, and widespread use of advanced technologies, including continuous glucose monitoring (CGM) systems and insulin pumps.
- Favorable reimbursement policies, substantial healthcare spending, and the strong presence of major industry players further promote innovation and the rapid adoption of new products.
- Moreover, increasing awareness of early diagnosis and effective disease management continues to drive demand for diabetes care devices across the region.
Europe
- Europe is gradually emerging as a key player in the diabetes care devices market, driven by the rising incidence of diabetes, robust healthcare infrastructure, and government initiatives promoting chronic disease management.
- The region has favorable reimbursement frameworks, increasing adoption of advanced technologies such as continuous glucose monitoring (CGM) systems and insulin pumps, and heightened awareness of early diagnosis and preventive care.
- Moreover, ongoing investments in research and innovation by leading industry players continue to bolster market expansion across European nations.
Asia-Pacific
- The Asia-Pacific region is rapidly establishing itself as one of the most dynamic and influential markets in the global diabetes care devices sector, driven by the rising prevalence of diabetes, large populations, and accelerating urbanization.
- Increased awareness of early diagnosis and effective disease management, coupled with the expansion of healthcare infrastructure, is boosting the adoption of glucose monitoring and insulin delivery devices.
- Furthermore, enhanced access to healthcare services, higher healthcare spending, and the growing integration of advanced technologies are driving market growth across major countries in the region.
Get a sneak peek at the diabetes care devices market dynamics @ Diabetes Care Devices Market Trends
Recent Developmental Activities in the Diabetes Care Devices Market
- In March 2026, Afon Technology announced that its Glucowear device demonstrated around 75% overall accuracy in identifying normal versus elevated blood glucose levels during its initial real-world clinical trial.
- In January 2026, Medtronic, a global leader in healthcare technology, announced that it had received U.S. Food and Drug Administration (FDA) 510(k) clearance for its MiniMed Go™ app.
- In August 2025, Signos launched the Signos Glucose Monitoring System, the first FDA-cleared, over-the-counter glucose monitoring system designed for weight management. The system integrates the Stelo by Dexcom glucose biosensor with an AI-powered platform, providing personalized, real-time insights into how diet, physical activity, stress, and sleep affect metabolic health.
- In July 2025, Medtronic plc. announced that it had received CE Mark in Europe to expand indications for the MiniMed™ 780G system to individuals aged 2 years and older, during pregnancy, and to those with type 2 insulin-requiring diabetes.
- In May 2025, GO-Pen ApS received FDA 510(k) clearance for the GO-PEN®, a user-filled insulin pen compatible with standard insulin vials, providing an affordable alternative to traditional disposable pens.
- In April 2025, Dexcom received FDA clearance for the G7 15-Day sensor, which boasts extended wear time and enhanced accuracy for diabetes management.
What are Diabetes Care Devices?
Diabetes care devices are specialized tools and technologies designed to help individuals monitor, manage, and control their blood glucose levels effectively. These devices include blood glucose meters, continuous glucose monitors (CGMs), insulin pumps, and smart pens, each serving a specific role in diabetes management. Blood glucose meters provide rapid snapshots of blood glucose levels, whereas CGMs offer real-time, continuous monitoring, alerting users to high or low levels. Insulin delivery devices, such as pumps and smart pens, enable precise administration of insulin according to individual needs. Together, these devices empower patients to maintain better glycemic control, reduce the risk of complications, and support a healthier, more independent lifestyle.
Diabetes Care Devices Market
Report Metrics
Details
Coverage
Global
Study Period
2023-2034
Diabetes Care Devices Market CAGR ~7%
Diabetes Care Devices Market Size
by 2034
~USD 76 Billion
Key Diabetes Care Devices Becton, Dickinson and Company, Novo Nordisk A/S, Ypsomed Holding AG, Tandem Diabetes Care, Inc., Biocon Ltd.,
Companies Eli Lilly and Company, Insulet Corporation, Abbott, Terumo Corporation, CeQur, EOFLOW CO., LTD, Sanofi,
Medtronic, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Dexcom Inc., ARKRAY, Inc., Senseonics,
WaveForm Technologies, Inc., B. Braun Melsungen AG, and others
Diabetes Care Devices Market Assessment
-
Diabetes Care Devices Market Segmentation
- Diabetes Care Devices Market Segmentation By Product Type: Blood Glucose Monitoring Devices {Wearable and Non-Wearable, Insulin Delivery Devices {Insulin Syringes, Insulin Pens, Insulin Pumps, and Others} and Integrated Systems
- Diabetes Care Devices Market Segmentation By Monitoring: Self-Monitoring and Continuous Monitoring
- Diabetes Care Devices Market Segmentation By Patient Type: Type 1, Type 2, and Gestational Diabetes
- Diabetes Care Devices Market Segmentation By End-User: Hospitals & Clinics, Homecare Settings, and Others
- Diabetes Care Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
-
Porter’s Five Forces Analysis, Product Profiles,
Case Studies, KOL
‘
s Views, Analyst
‘
s View
Which MedTech key players in the diabetes care devices market are set to emerge as the trendsetter explore @ Diabetes Care Devices Market Analysis
Table of Contents
1 Diabetes Care Devices Market Report Introduction
2 Diabetes Care Devices Market Executive Summary
3 Diabetes Care Devices Market Key Factors Analysis
4
Impact Analysis
5
Regulatory Analysis
6 Diabetes Care Devices Market Porter’s Five Forces
Analysis
7
Diabetes Care Devices Market Assessment
8
Competitive Landscape
9
Startup Funding & Investment Trends
10 Diabetes Care Devices Market Company and Product
Profiles
11
KOL Views
12
Project Approach
13
About DelveInsight
14
Disclaimer & Contact Us
Interested in knowing the diabetes care devices market share by 2034? Click to get a snapshot of the Diabetes Care Devices Market Size
Related Reports
Blood Glucose Monitoring Devices Market
Blood Glucose Monitoring Devices Market Insights, Competitive Landscape and Market Forecast – 2034 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key blood glucose monitoring devices companies, including Medtronic, Abbott, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Dexcom Inc., ARKRAY, Inc., Senseonics, WaveForm Technologies, Inc., B. Braun Melsungen AG, Ascensia Diabetes Care Holdings AG., Ypsomed, i-SENS, Inc., Intuity Medical, Inc., ACON Laboratories, Inc., Prodigy Diabetes Care, LLC, Sinocare, Rossmax International Ltd., Menarini Diagnostics s.r.l., Bionime Corporation., Nemaura, and others.
Insulin Infusion Pumps
Market
Insulin Infusion Pumps
Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key insulin infusion pumps companies, including F. Hoffmann-La Roche Ltd, Medtronic, Medtrum Technologies Inc., A. Menarini Diagnostic’s s.r.l., IA Collaborative Holdings, LLC, Apex Medical, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Ypsomed AG, Tandem Diabetes Care, Inc., ICU Medical, Inc., SOOIL Developments Co., Ltd., MicroPort Scientific Corporation, Microtec Medical, and others.
Insulin Pens
Market
Insulin Pens
Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key insulin pens companies, including Novo Nordisk A/S, Owen Mumford Ltd, Sanofi Diabetes, Merck Sharp & Dohme Corp., Insulet Corporation., Biocon Ltd., B. Braun Melsungen AG, Eli Lilly and Co., DIABETIC PROMOTIONS., Ypsomed Logo, Medtronic., BERLIN-CHEMIE AG, pendiq., Emperra GmbH E-Health Technologies, Digital Medics Pty Ltd., delfu-medical, Diamesco Co. Ltd. e, Becton, Dickinson and Company., Vansea Medical, Montmédand, and others.
Smart Insulin Pens
Market
Smart Insulin Pens
Market Insights, Competitive Landscape, and Market Forecast – 2034 report deliver an in-depth understanding of the market trends, market drivers, market barriers, and key smart insulin pens companies, including Emperra GmbH E-Health Technologies, Jiangsu Deflu Medical Device Co. Ltd., Medtronic, Novo Nordisk A/S, Pendiq., Sanofi, Berlin-Chemie, Bigfoot Biomedical, Digital Medics Pty Ltd., Eli Lilly and Company, Ypsomed, Dexcom, Inc., and others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact UsShruti [email protected]+14699457679
Logo: https://mma.prnewswire.com/media/1082265/3528414/DelveInsight_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/global-diabetes-care-devices-market-to-accelerate-substantially-at-a-cagr-of-7-by-2034–delveinsight-302715541.html
Tengo varias preguntas sobre esto a ver si me podiais aclarar:
-¿Puedo hacer un ingreso regular de 800 euros y me cobran 0euos de comisiones y mto.?
-¿Puedo sacar el dinero cuando quiera?,¿todo ó tengo entendido que hay que mantener un mínimo de 100 euros los 30 meses?
-No necesito pero me obligan a sacar una tarjeta de débito que me cuesta 11 euros el primer año y 22 euros la renovación, también otra de credito que me cuesta 0 euros el primer año y 35 euros la renovación.
¿Hay que mantenerlas 13 meses?
¿Puedo cancelar alguna de ellas desde el principio?
¿Puedo cancelar alguna de ellas antes de la renovación?
¿Hay alguna tarjeta de credito más barata?
Aparte de la cuenta nómina he visto que también que para que te den la tv también se puede sacar una cuenta tarifa plana básica o personal, ¿sabeis algo de estas cuentas?¿que requisitos tienen?
Muchas gracias a todos por responder
Yo fui a informarme y te cuento. Únicamente admiten los ingresos regulares en el caso de que seas autónomo. Te abren una cuenta Tarifa Plana Cero que está exenta de comisiones y presenta alguna ventaja más. Sobre dejar un mínimo de saldo en la cuenta no es necesario, pero sí te obligan a mantener varias tarjetas durante los 30 meses con un coste aproximado de 100 euros anuales.
hola buenas!
me llamo javi y estoy dudando de que banco, me puede dar mas beficios, sin sorpresas por domiciliar la nomina, ya que llevo años en la caixa y no me da nada ningun beneficio. es mas me rechazan los prestamos que solicito, ni siquiera una targeta de credito, por alegan de que siempre esta a cero la cuenta, yo cuando cobro la nomina dejo el dinero para los pagos, y saco el resto, pues no me fio, de que un dia me quede sin dinero, ya que esta todo muy mal, corre riesgo mi dinero o mis ahorros en el banco?? muchas gracias y un cordial saludo.
javi
NO TE EXTRAÑE QUE NO TE DEN LOS PTMOS, PORQUE LO QUE VEN ES QUE NO TIENES CAPACIDAD DE AHORRO PORQUE SIEMPRE DEJAS LA CTA. EN MINIMOS, ASI NINGUN BANCO TE LO VA A CONCEDER. TAMBIEN ES VERDAD QUE LA CAIXA, COMO TANTAS OTRAS CAJAS, TIENE EL PUÑO CERRADO PARA LOS RIESGOS, PARA REMONTAR. NO TE PREOCUPES, QUE POR UNA NOMINA NO CREO QUE NINGUN BANCO SE COJA LAS MANOS. LOS QUE SE TIENEN QUE PREOCUPAR SON LOS QUE TIENEN DÉPÓSITOS Y FONDOS EN BANCOS DE DUDOSA ACTIVIDAD. LA GENTE SE PIENSA QUE PORQUE LES DEN UN 7% YA ES UN GRAN BANCO Y SE EQUIVOCAN. LO QUE LES PASA ES QUE EL BANCO DE ESPAÑA LES PRESTA EL DINERO MAS CARO Y POR ESO OPTAN POR CONSEGUIRLO EN EL MERCADO MONETARIO, Y SI EL BANCO DE ESPAÑA NO SE FIA DE ELLOS, VA Y SE FIA LA GENTE. QUE LOS BANCOS NOES LA ADMON PUBLICA, ABRAN OS OJOS.
Hola , cuando vallais al banco queos dejen lo que hay que pagar de irpf y de iva sobre el valor de la tele ya que en la mayoria de bancos esto no lo dicen y luego llagan las sorpresas .A mi ya me ha pasado con la promoción del portatil y nunca me hablaros de esto . Cuidado
Yo he estado calculando y la tele entre unas cosas y otras te sale sobre unos 250euros que tampoco regalan tanto .Hay oficinas en las que han dado la occión de poner un dinero a plazo fijo a 12meses de 9300euros o 6800euros a 18 meses.
No es ningún chollo. Te obligan a contratar dos tarjetas de crédito que tienes que pagar porque las tienes que mantener 13 meses por lo menos y además llevan unos costes desproporcionados si las utilizas. En total, no usando las tarjetas y anulándolas una vez cumplidos los 13 meses puedes ahorrar unos 38 euros con respecto al precio de ese televisor en una gran superficie. Y además luego vendrá que te cobran para hacienda la retención correspondiente, por lo que probablemente incluso en las mejores condiciones te cueste más que si ahorras un poco y lña compras directamente.
Creó que teneis toda la razón, que aqui no te regalan nada, ya que a mí me paso con unas sartenes que regalaban el banco bilbao, que al final entre el irpf y el descuento de Hacienda, al final me salieron caras, así es que no os tomen el pelo, que al final siempre esta la letra pequeña que es la que nos joroba, por no decir otra cosa.
Yo saque el portatil y ahora me he sacado la TV LCD 32. Estas promos no hay que declararlas. No es obligado domiciliar nomina. Si, meter en la cuenta 800€ todos los meses en un margen de 10 dias. Cero matacero, pero cero,cero, cero de gastos de mantenimiento, ni por recibos, ni por el correo a casa, ni por transfer. Las tarjets gratis el 1er año. Resto fuera. Dadas de baja Menos la de debito. Banesto no pierde nada, ganar, gana clientes que es el proposito de esta promo. Precio de portatil y tv 32 en mercao unos 900€ los 2. En banest 197€. Los hay mejores, nos ha jodio! portatiles a 1200€, TV LCD 32 a 1000€. Señores, son lentejas. Relacion calida-precio-promo es cojonud…….Un saludit a los viandantes.
hola , no se si llegara mi comentario pero os voi a esplicar. esto es el cuento de la abuela. mira yo tengo el portatil. y he cogio tab la tele, pero sabeis ke?, me ha pasado de todo. os esplico. primero me cobran 74 euros y 25 euros de unas tarjetas que yo no las he visto aparecer por mi casa , me cabreo con el banco. llamo y pido esplicaciones. me dicen que van en la promocion, nunca jamas nadie me informo de las tarjetas, no me devuelven el dinero. me cabreo y me dicen que llame aun numero de tefono para darlas de baja, se pasan los dias, intentamos darlas de baja. largas y larga, que si este numero de tefono que si el otro bla bla bla. conseguimos hablar y nos dicen que tenemos que cambiar el contrato a tarifa plana o no se ke historias, llamando al banco se pasan los dias, largas y largas. me cabreo y estoi por suspender todo, me dicen que si lo quiero cambiar y dar de baja las tarjetas que nunca he tenido. tengo que pagar comisiones cada seis meses de doce y pico euros, y que si no quiero que me cobren comisiones tengo que ir todos los meses al banco a hacerlo yo, ufffffffffff.aun hay mas. me dan de baja y me hacen la tarifa plana, se equivocan un monton de veces. me hacen pasar muchos cabreos.y al final cuando llego a casa me han cobrado 25, 50 euros. y llamo por telefono y se lo digo , me dicen claro por dar de baja la otra cuenta , la madre que los pario. ladrones. o sea os digo que la tele no sale regalada, se la cobran y muy bien cobrada , nadie da nada por nada. en cuento termine de pagar lo que debo quito todas las cuentas del banesto.espero que alguien me lea y que me conteste gracias .
Banesto ha jodido a mi marido y a un amigo tambien. Para mi, despues de Banco de Andalucía son los peores. Y quieran creerlo o no ni la television ni el portátil te lo regalan.. como no cumplas cualquiera de las reglas te sancionan con 300 y pico de euros.. porque nos hemos mudado de casa y los recibos domiciados se cortaron «temporalmente» la sancion fue de mas de 300 euros.. y el cabreo q te llevas cuando ves lo q te han descontado y luego para ir a reclamarlos.. y como te tratan !! en fin.. espero que Banesto sea lo primero en undirse en el fin del mundo!!
CHOLLO!!!!!!!!!JAJAJAJAJA…….NO ES NINGUN CHOLLO!!!!!!! te cobran 100 € de gastos de manipulacion, mas 150 € en tarjetas durante 2 años, mas 6 € mensuales de mantenimiento de cuenta durante 30 meses, total que pagas 630 Euros por un ordenador o una TV que su valor seguro que no llega a 500 €. Y encima si vas a cancelar la cuenta cuando cumples los 30 meses requeridos te hacen esperar dos horas para decirte que no tienen linea de telefono para dar de baja la cuenta, cosa que no para nunca cuando vas a contratarlo. Y del trato que dispensan….., es el mismo que si vas con un fajo de billetes de 500 € por los CO-JONES
Banesto «premia», menuda falacia…
No hay ningún banco que premie a nadie.
BANESTO NECESITA NUESTRAS NÓMINAS, Y EN CUANTO VAS UN POCO JUSTO, COMO BUENOS JUDÍOS Y ÁVAROS QUE SON, TE ACOSAN Y MACHACAN, Y TE SACAN HASTA LAS ENTRAÑAS EN COMISIONES.
DESPUÉS EL ESTADO APOYA A LOS BANCOS, CON LA EXCUSA DE QUE SI CAEN LOS BANCOS CAEMOS TODOS. LOS BANCOS NECESITAN UN BOICOT DE VEZ EN CUANDO, PARA QUE NO NOS RESTREGUEN POR LA CARA SUS BENEFICIOS.
POR CIERTO, LO QUE MÁS FASTIDIA A UN BANCO ES UNA RECLAMACIÓN EN LA OFICINA DEL CONSUMIDOR Y OTRA AL BANCO DE ESPAÑA.
ES POR DAR PISTAS…